References
- Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature. 2009;459:931–939.10.1038/nature08157
- Gupta RK, Nguyen-Van-Tam JS. Oseltamivir resistance in influenza A (H5N1) infection. N. Engl. J. Med. 2006;354:1423–1424.
- Jong MD, Bach VC, Phan TQ, et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N. Engl. J. Med. 2005;353:2667–2672.10.1056/NEJMoa054512
- Yamamoto T, Izumi N, Ui H, et al. Wickerols A and B: novel anti-influenza virus diterpenes produced by Trichoderma atroviride FKI-3849. Tetrahedron. 2012;68:9267–9271.10.1016/j.tet.2012.08.066
- Altschul SF, Madden TL, Schäffer AA, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997;25:3389–3402.10.1093/nar/25.17.3389
- Omura S, Hirano A, Iwai Y, Masuma R. Herquline, a new alkaloid produced by Penicillium herquei. Fermentation, isolation and properties. J. Antibiot. 1979;32:786–790.10.7164/antibiotics.32.786
- Enomoto Y, Shiomi K, Hayashi M, et al. Herquline B, a new platelet aggregation inhibitor produced by Penicillium herquei Fg-372. J. Antibiot. 1996;49:50–53.10.7164/antibiotics.49.50
- von Itzstein M. The war against influenza: discovery and development of sialidase inhibitors. Nat. Rev. Drug Discov. 2007;6:967–974.10.1038/nrd2400
- Kim JH, Resende R, Wennekes T, et al. Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity. Science. 2013;340:71–75.10.1126/science.1232552
- Hokari R, Nagai T, Yamada H. In vivo anti-influenza virus activity of Japanese herbal (kampo) medicine, "shahakusan," and its possible mode of action. Evid.-based Complement Altern. Med., 2012, 794970.
- Denisova OV, Soderholm S, Virtanen S, et al. Akt inhibitor MK2206 prevents influenza pH1N1 virus infection in vitro. Antimicrob. Agents Chemother. 2014;58:3689–3696.10.1128/AAC.02798-13